Cardlytics
CDLX
78 hedge funds and large institutions have $491M invested in Cardlytics in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 31 increasing their positions, 17 reducing their positions, and 10 closing their positions.
170% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 10
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
84% more capital invested
Capital invested by funds: $266M → $491M (+$224M)
82% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 17
26% more funds holding
Funds holding: 62 → 78 (+16)
1.22% more ownership
Funds ownership: 7.15% → 8.37% (+1.2%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $6.85M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
CAS Investment Partners
Westport,
Connecticut
|
+$43.3M |
| 2 |
BlackRock
New York
|
+$8.78M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$8.01M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$6.9M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$11.6M |
| 2 |
CPV
Canaan Partners VIII
Westport,
Connecticut
|
-$9.71M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$8.33M |
| 4 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$5.51M |
| 5 |
GIPM
G2 Investment Partners Management
New York
|
-$3.07M |
CDLX Hedge Fund Activity: Q2 2019 in Review
78 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q2 2019, worth a combined $491M — up 84% from $266M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new CDLX positions and 10 closed out — a net gain of 17 holders — while 31 added to existing stakes and 17 trimmed.
The largest buyer was CAS Investment Partners, opening a new position worth an estimated $43.3M. The largest seller was Frontier Capital Management, cutting an estimated $11.6M.
- 78 institutional investors held Cardlytics (CDLX) as of Q2 2019, up from 62 in Q1 2019.
- Funds reported $491M of Cardlytics stock for Q2 2019, up 84% quarter-over-quarter.
- 27 funds opened new Cardlytics positions in Q2 2019 and 10 closed out, a net change of +17 holders.
- The largest Cardlytics buyer in Q2 2019 was CAS Investment Partners, an estimated $43.3M added.
- The largest Cardlytics seller in Q2 2019 was Frontier Capital Management, an estimated $11.6M sold.
Based on aggregated 13F filings for Q2 2019.